MREO
Mereo BioPharma
MREO
MREO
79 hedge funds and large institutions have $362M invested in Mereo BioPharma in 2024 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 27 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 15
1% less funds holding
Funds holding: 80 → 79 (-1)
26% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 27
Holders
79
Holding in Top 10
1
Calls
$2.8M
Puts
$1.75M
Top Buyers
| 1 | +$24.2M | |
| 2 | +$15.8M | |
| 3 | +$9.95M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$8.87M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$6.32M |
Top Sellers
| 1 | -$12.9M | |
| 2 | -$4.93M | |
| 3 | -$4.23M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.27M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.81M |